Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590330 · ClinicalTrials.gov registry record
Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 55
- Enrollment target
NCT00590330: Completed study, sponsored by Boston Children's Hospital.
NCT00590330 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00590330 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to identify all the bacterial species present in the respiratory tracts of patients with Cystic Fibrosis (CF), and to connect them with clinical information. Traditional culture methods of throat swab and sputum samples can only identify the most prevalent bacteria in samples, those of which there are over about 5 million bacteria per teaspoon. A recently developed method has been found to be more sensitive and can detect up to several hundred bacterial species in throat swab or sputum sample of individual CF patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-03 |
What the finished NCT00590330 record still lists
NCT00590330 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00590330 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00590330 about?
NCT00590330 is a clinical study titled "Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs". The purpose of this study is to identify all the bacterial species present in the respiratory tracts of patients with Cystic Fibrosis (CF), and to connect them with clinical information. Traditional culture methods of throat swab and sputum samples can only identify the most prevalent bacteria in sa...
What is the current status of trial NCT00590330?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2007-10. Estimated completion is 2009-03.
Who is sponsoring clinical trial NCT00590330?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia